Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I
- PMID: 16188808
- DOI: 10.1111/j.1651-2227.2005.tb02004.x
Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I
Abstract
Aim: To review the heterogeneity and severity of the clinical features at the attenuated end of the mucopolysaccharidosis (MPS) type I disease spectrum.
Methods: The course of disease in 29 patients with attenuated mucopolysaccharidosis I who attended the MPS clinic in Manchester, UK, was reviewed.
Results: For more than half of the patients, onset of symptoms was in the first 2 y of life, and the age at diagnosis ranged from 15 mo to 40 y. Joint stiffness, corneal clouding, umbilical hernia and recurrent ear, nose and throat symptoms were the commonest features at presentation. Patients experienced significant morbidity during the course of this inherited disease. Skeletal problems predominated and cardiac valve pathology, upper airway obstruction and hearing deficits were detected in a notable number of patients. Nerve decompression for carpal tunnel syndrome, cervical cord decompression, and grommet insertion for serous otitis media were the most frequent surgical interventions.
Conclusion: Clinical presentation of attenuated ("non-Hurler") mucopolysaccharidosis type I is heterogeneous in time of onset and types of clinical features. A better understanding of the spectrum of disease and of the related disease progression will contribute to more accurate diagnosis, and patients will benefit from early intervention.
Similar articles
-
Mucopolysaccharidosis type I.Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:102-6. Pediatr Endocrinol Rev. 2014. PMID: 25345091 Review.
-
Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.Int J Pediatr Otorhinolaryngol. 2020 Aug;135:110137. doi: 10.1016/j.ijporl.2020.110137. Epub 2020 May 27. Int J Pediatr Otorhinolaryngol. 2020. PMID: 32502916
-
Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I.J Inherit Metab Dis. 2010 Aug;33(4):421-7. doi: 10.1007/s10545-010-9113-7. Epub 2010 Jun 2. J Inherit Metab Dis. 2010. PMID: 20532982 Free PMC article.
-
Early disease progression of Hurler syndrome.Orphanet J Rare Dis. 2017 Feb 14;12(1):32. doi: 10.1186/s13023-017-0583-7. Orphanet J Rare Dis. 2017. PMID: 28193245 Free PMC article.
-
Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review.Cardiovasc Pathol. 2014 May-Jun;23(3):145-51. doi: 10.1016/j.carpath.2014.01.001. Epub 2014 Jan 10. Cardiovasc Pathol. 2014. PMID: 24508139 Review.
Cited by
-
Restricted upper extremity range of motion in mucopolysaccharidosis type I: no response to one year of enzyme replacement therapy.J Inherit Metab Dis. 2007 Feb;30(1):47-50. doi: 10.1007/s10545-006-0490-x. Epub 2006 Dec 11. J Inherit Metab Dis. 2007. PMID: 17160613
-
Mucopolysaccharidosis Type 1 among Children-Neuroradiological Perspective Based on Single Centre Experience and Literature Review.Metabolites. 2023 Jan 31;13(2):209. doi: 10.3390/metabo13020209. Metabolites. 2023. PMID: 36837830 Free PMC article.
-
Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I.Arch Dis Child. 2021 Jul;106(7):674-679. doi: 10.1136/archdischild-2020-319040. Epub 2020 Nov 2. Arch Dis Child. 2021. PMID: 33139350 Free PMC article.
-
Mucopolysaccharidosis type I Hurler-Scheie syndrome: A rare case report.Contemp Clin Dent. 2011 Jan;2(1):66-8. doi: 10.4103/0976-237X.79287. Contemp Clin Dent. 2011. PMID: 22114460 Free PMC article.
-
Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure.Orphanet J Rare Dis. 2012 Apr 23;7:22. doi: 10.1186/1750-1172-7-22. Orphanet J Rare Dis. 2012. PMID: 22524701 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical